DrugPatentWatch Database Preview
INFLAMASE MILD Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which patents cover Inflamase Mild, and what generic alternatives are available?
Inflamase Mild is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in INFLAMASE MILD is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
Summary for INFLAMASE MILD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 39 |
| Patent Applications: | 3,993 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | INFLAMASE MILD at DailyMed |
Synonyms for INFLAMASE MILD
| [2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] dihydrogen phosphate |
| 11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(disodium phosphate) |
| 125-02-0 |
| 1263143-23-2 |
| A805337 |
| AC1L1J72 |
| AC1L1LDT |
| AC1L9B41 |
| AKOS025310687 |
| AKOS025394281 |
| AN-14017 |
| API0003920 |
| AT-2935 |
| BCP11881 |
| C21H27O8P.2Na |
| CHEMBL1201014 |
| Codelsol |
| Cortisate-20 (Veterinary) |
| CS-2878 |
| CTK8I0968 |
| D00981 |
| D3918 |
| disodium [2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl] phosphate |
| disodium [2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] phosphate |
| disodium [2-[(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] phosphate |
| disodium [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate |
| Disodium prednisolone 21-phosphate |
| disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate |
| DTXSID2047480 |
| EINECS 204-722-9 |
| EINECS 206-120-1 |
| FT-0631728 |
| HY-B0645 |
| Hydeltrasol |
| I06-0770 |
| Inflamase |
| Inflamase Forte |
| IV021NXA9J |
| KB-296232 |
| LS-118502 |
| LS-174283 |
| Metreton |
| Millipred |
| MolPort-019-991-120 |
| NCGC00249889-01 |
| Optimyd |
| Optival |
| Pediapred (TN) |
| Phortisolone |
| Predair |
| Predair Forte |
| Prednesol |
| Prednisolone (disodium phosphate) |
| Prednisolone 21-(dihydrogen phosphate) |
| Prednisolone 21-(disodium phosphate) |
| Prednisolone 21-phosphate disodium |
| Prednisolone 21-Phosphate Disodium Salt |
| Prednisolone disodium phosphate |
| Prednisolone phosphate sodium |
| prednisolone sodium phosphate |
| Prednisolone sodium phosphate (JP17/USP) |
| Prednisolone Sodium Phosphate [USAN:JAN] |
| Prednisolone sodium phosphate [USP:JAN] |
| Predsol |
| Predsolan |
| Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-(dihydrogen phosphate), disodium salt |
| Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-(dihydrogen phosphate),disodium salt |
| Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11.beta.)- |
| Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11beta)- |
| Prozorin |
| SCHEMBL1650407 |
| SCHEMBL23563 |
| Sodium prednisolone phosphate |
| Solucort |
| ST24049032 |
| UNII-IV021NXA9J |
| VA11575 |
| Vasocidin Solution |
| Veripred 20 |
US Patents and Regulatory Information for INFLAMASE MILD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | INFLAMASE MILD | prednisolone sodium phosphate | SOLUTION/DROPS;OPHTHALMIC | 080751-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
